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Genome-wide association study of 
emotional empathy in children
M. R. Woodbury-Smith  1,2 ✉, A. D. paterson2,3, P. Szatmari2,3,4 & S. W. Scherer  2,4,5
The genetic contribution to different aspects of empathy is now established, although the exact 
loci are unknown. We undertook a genome-wide association study of emotional empathy (ee) as 
measured by emotion recognition skills in 4,780 8-year old children from the ALSPAC cohort who 
were genotyped and imputed to Phase 1 version 3 of the 1000 Genomes Project. We failed to find 
any genome-wide significant signal in either our unstratified analysis or analysis stratified according 
to sex. A gene-based association analysis similarly failed to find any significant loci. In contrast, our 
transcriptome-wide association study (TWAS) with a whole blood reference panel identified two 
significant loci in the unstratified analysis, residualised for the effects of age, sex and IQ. One signal was 
for CD93 on chromosome 20; this gene is not strongly expressed in the brain, however. The other signal 
was for AL118508, a non-protein coding pseudogene, which completely lies within CD93’s genomic 
coordinates, thereby explaining its signal. Neither are obvious candidates for involvement in the brain 
processes that underlie emotion recognition and its developmental pathways.
Our capacity to negotiate the complexity of the social world represents the remarkable evolutionary development 
of a wide range of mechanisms for the processing of social information. Some of our most advanced skills, such 
as language and empathy, mediate our interaction with our social environment1,2. These skills are crucial in navi-
gating our social milieu, in terms of independent living, vocational success and wider interpersonal relationships. 
Empathy itself, referring to the ability to share an emotional experience with another person, has been extensively 
studied from a biological perspective3. Two dimensions of empathy are widely recognised, namely emotional and 
cognitive empathy3. The former essentially describes the process of emotional isomorphism with another person, 
i.e. the sharing of their emotional state. Consequently, it requires the decoding of that information from cues 
offered by others’ facial expressions, vocalisations, and gestures4. In contrast, cognitive empathy refers to the abil-
ity to understand more complex mental states, and is therefore more closely aligned with the concept of theory 
of mind (ToM) or mentalizing5–7. From an evolutionary perspective, although attachment and parental care are 
observed across species, empathy is only truly developed in mammals that possess self-awareness, demonstrable 
among primates but very few other animals. Phylogenetically, emotional empathy is older and less complex, with 
ToM also requiring the ability to perspective take8.
Using a variety of experimental paradigms research is now beginning to unravel the brain’s mechanisms for 
empathy. For example, much progress has been made in delineating the underlying neuropsychological dimen-
sions of both emotional and cognitive empathy using a variety of experimental paradigms9. These same dimen-
sions have also been mapped onto brain networks using functional neuroimaging10. Although a full taxonomy is 
far from clear, the amygdala and its prefrontal and superior temporal connections are known to play a crucial role 
in the processing of social information, thereby mediating elements of empathy10.
Twin and family studies have demonstrated that the different aspects of empathy are heritable, but increas-
ingly influenced by shared environmental factors as a child grows. Specifically, Hughes and Cutting11 calculated 
a heritability of 67% (95% CI: 26–79%, best fitting model χ2(4) = 0.79, n.s., AIC = −7.21) for cognitive empathy 
for 3-year old twin pairs using a false belief paradigm, but by 5 years shared environment became increasingly 
important12. Autism Spectrum Disorder (ASD), a developmental disorder in which an abnormality of social 
interaction is a core impairment, is also known to be principally genetic in aetiology, with more than 100 genes or 
genomic regions harbouring rare genetic variants implicated so far13. Additionally, there is emerging evidence for 
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the role of more common variants, sometimes coupled with rare variants, consistent with the genetic landscape 
of other neurodevelopmental and complex medical disorders14,15.
Recently, efforts have also been underway to identify common genetic variants that may be associated with 
different aspects of social cognition. For example, Warrier and colleagues conducted a genome-wide association 
(GWA) study of cognitive empathy using customers from 23 and Me and subjects from the Brisbane Longitudinal 
Twin Study16. Heritability for cognitive empathy was estimated at 5.8% (95% CI: 4.5–7.2%; p = 1 × 10−17), with 
a female specific locus at 3p26.1 reaching genome-wide significance. The leading SNP and the other 21 SNPs 
in high linkage disequilibrium with it are near LRRN1, which is highly expressed in brain tissue17. In a separate 
study, Warrier and Baron-Cohen18 also investigated the genetics of cognitive empathy using data from the Avon 
Longitudinal Study of Parents and Children, a prospective birth cohort study (ALSPAC, see below). Among 
teenagers, no GWA significant signal was identified, and SNP-based heritability was negligible (0.13%, p = 0.16). 
One limitation may have been the task used to measure cognitive empathy, the ‘Triangles Task’, which, although 
validated for ToM19, has little ecological validity.
In contrast, Coleman and colleagues20 investigated common variants associated with emotion recogni-
tion as measured by the Diagnostic Analysis of Nonverbal Accuracy Scale (DANVA)21 in the same ALSPAC 
dataset. Theirs did not find any associated variants, and nor did they identify a heritable component from SNP 
based heritability. However, a potential confound in Coleman et al.’s analyses is population stratification, which 
was not fully taken into consideration. Moreover, other layers of analysis, such as gene based association and 
transcriptome-wide association, provide additional opportunities for identifying signals that may be otherwise 
not seen in GWAS.
Therefore, in this current study ALSPAC data were used to investigate emotional empathy (EE) using the 
Diagnostic Analysis of Nonverbal Accuracy Scale (DANVA)21. Specifically, we examined the common genetic 
architecture of EE among 8-year old males and females evaluated using an established EE paradigm and geno-
typed and imputed to Phase 1 version 3 of the 1000 Genomes Project22. Further downstream analyses, including 
gene based and transcriptome-wide association along with polygenic risk score predictive analysis, were also 
undertaken.
Results
The total sample comprised 4,780 children (males: 2,382, females: 2,393; ratio ~ 1:1) with a mean age at time 
of assessment of 103.6 months (SD: 3.7 months). There was no difference between the mean ages of males and 
females (males: mean (SD) 104 months (3.8); females: mean (SD) 104 months (3.6). The mean (SD) IQ (full scale 
IQ) assessed at the same age was 105.1 (16.4) for the complete sample, with no sex difference (males: mean (SD) 
105 (16.9); females: mean (SD) 105 (15.7).
The total raw DANVA score (max. 24) did not follow a normal distribution (Supplementary Fig. 1: DANVA3 
distribution). A cubed transformation of the raw scores improved distributional properties towards normality. 
DANVA3 was therefore used as the trait measure in all subsequent analyses. Both age and IQ were significantly 
correlated with DANVA3 scores, and DANVA3 scores differed significantly between males and females (DANVA3 
scores: female > male, effect size = 0.2, p = 1.4 × 10−8). Our principal GWAS analyses therefore examined 
DANVA3 residualized for the effects of age, sex and IQ. As a corollary, and in order to be able to directly compared 
results to those of Warrier et al.16,18, we also conducted analyses residualizing for only age and sex.
Genome-wide association. All individuals were of European ancestry according to our population 
stratification analysis (see methods). We further investigated for confounding using LDSC23 using LD scores 
calculated from 1000 Genomes European samples. An LDSC intercept of 0.99 (SE = 0.006) was generated 
(lambda-GC = 0.99). This intercept of less than 1 is consistent with the absence of population stratification. A 
SNP heritability of 3.25% (SE 8.8%) was obtained. The results of the GWA analysis for emotional empathy across 
all autosomes, as measured by total DANVA3 score residualized for the effect of sex, age and IQ, are depicted 
in Fig. 1. The three analyses include total sample, and further analyses stratified by sex. These analyses did not 
identify any SNPs significant at the p < 5 × 10−8 level. In the female-only analysis the most significant locus 
identified was on chromosome 1 (rs12407722, β = −1151.37, se = 212.7, p = 5.6 × 10−8, male: β = 102.3, se = 
224.5, p = 4.476e-06). This SNP lies in an intergenic region. The next most significant loci were in the male only 
analysis on chromosome 17 (rs2032753, β = 411.0, se = 80.2, p = 3.21 × 10−7, a MYO1D intronic variant), chro-
mosome 4 (rs7686071, −β = 564.53, se = 111.9, p = 4.8 × 10−7, intergenic) and chromosome 7 (rs113791338, β 
= −1134.17, se = 224.2, p = 4.79 × 10−7, a CALN1 intronic variant). None of these loci overlap with the Warrier 
et al. cognitive empathy loci16. Additionally, none overlapped the top SNPs from the Coleman et al. study. All 
SNPs with p < 1 × 10−6 are provided in Supplementary Table 1.
We also undertook a GWA analysis of total DANVA3 score residualized for the effect of sex and age. The 
results are shown in Supplementary Fig. 2. The GWA analysis did not identify any significant SNPs either for the 
complete sample or when stratified by sex. Again, none of the loci where non-significant signals were apparent 
overlapped the loci highlighted by Warrier et al.16 Additionally, none overlapped the top SNPs from the Coleman 
et al. study. All pruned SNPs with p < 1 × 10−6 are provided in Supplementary Table 2.
We additionally investigated direction of effects for Warrier et al.’s top 10,000 SNPs to examine concord-
ance with our own analyses. We first LD pruned these SNPs using LDlink’s SNPclip option based on the 1000 
genomes phase 3 (version 5) dataset24. We then examined the distribution of the p values for these same SNPs 
from our ALSPAC GWAS, and tested those p values for deviation from a uniform distribution using the 
Kolmogorov-Smirnov test. Our data were consistent with uniformity, indicating lack of directional concordance 
(D = 0.99, p-value = 0.38).
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Gene-based association. We next undertook a gene-based association test for a total of 15,056 auto-
somal genes using MAGMA [v.1]25. No gene passed the genome-wide threshold for significance (Bonferroni 
0.05/15056 = 3.3 × 10−6) (Supplementary Fig. 3 [residualized for IQ, age and sex]; Supplementary Fig. 4 [residu-
alized for age and sex]). Of the four genes with smallest p-values, three were from the male only analysis on chro-
mosomes 6 (ALDH5A1, p = 2.1 × 10−5), 11 (C11orf44, p = 3.4 × 10−5) and 17 (MYO1D, 3.4 × 10−5). This gene 
was also identified by the intronic variant signal at rs2032753 in the GWAS. The other gene was from the corollary 
female only analysis (i.e. residualizing for only age and sex) on chromosome 12 (TM7SF3, p = 3.9 × 10−5).
transcriptome-wide association. We undertook a TWAS with 2057 genes using weights derived from 
GTEx whole blood samples [V.6] as described in Gusev et al.26. Two signals from the non-stratified analysis 
Figure 1. Manhattan (left) and QQ (right) plots for GWAS, unstratified (top), female only (middle), male only 
(bottom). Note y-axis starts at −log10(P) = 1.
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residualized for age, sex and IQ were significant at the Bonferroni corrected level of significance (0.05/2057 = 2.4 
× 10−4), with under expression of the genes positively associated with emotional empathy (CD93, p = 7.6 × 
10−5 and AL118508, p = 1.6 × 10−4). (Supplementary Fig. 5 [residualized for IQ, age and sex]; Supplementary 
Fig. 6 [residualized for age and sex]). The coordinates of these two genes indicate that AL118508 is in fact a 
non-expressed pseudogene that lies entirely within the larger CD93. Its signal is therefore simply an artifact of the 
overlap with CD93.
polygenic risk. Polygenic risk scores were calculated for ASD27, schizophrenia28, bipolar disorder29, educa-
tional attainment30, cognitive performance30 and obsessive-compulsive disorder31. No correlation was observed 
between polygenic scores and EE for ASD, schizophrenia, bipolar disorder and obsessive-compulsive disorder 
across the range of P-value thresholds for the complete sample and also when covarying for sex (Supplementary 
Fig. 7). For emotional attainment there was evidence of significant positive correlation across a range of p-value 
thresholds, although only limited variance was predicted by the model (Supplementary Fig. 7). For cognitive 
performance, a marginally significant positive result was obtained at one p-value threshold.
Discussion
We undertook a genome-wide association study of emotional empathy as measured by emotion recognition skills 
in 4,780 8-year old children. We failed to find any genome-wide significant signal in either our unstratified analy-
sis or analysis stratified according to sex. A gene-based association analysis similarly failed to find any significant 
loci. In contrast, our TWAS identified two significant loci in the unstratified analysis, residualised for the effects 
of age, sex and IQ. CD93 on chromosome 20 is not strongly expressed in either the adult or the developing brain 
(https://www.ebi.ac.uk/gxa/genes/). AL118508, also on chromosome 20, is a non-protein coding pseudogene, 
whose coordinates lie within those of AL118508, which explains its signal. Neither are obvious candidates for 
involvement in the brain processes that underlie emotion recognition and its developmental pathways. Given the 
recent suggestive findings of new potential mechanisms involved in ASD, however, these genomic regions should 
be further scrutinized32–35.
Among the non-significant findings, signals are either intergenic or overlapping genes that are not strongly 
brain expressed or implicated in brain development. The one exception is MYO1D, identified in both GWAS and 
gene-based association for the male only analysis. This gene encodes a widely expressed protein which is also 
strongly expressed in the developing brain36 and is in a region that has previously shown evidence of linkage to 
the neurodevelopmental disorder autism spectrum disorder37. This is particularly significant as ASD is known to 
be associated with impairments in the ability to decode emotional expressions in faces10.
None of the signals identified in our study overlap those of Warrier et al. in their GWAS study of cognitive 
empathy on the same sample, nor with the Coleman et al. study in the same sample. This may be unsurprising 
since these studies are likely underpowered based upon their sample sizes. Indeed, the importance of sample size, 
and the approximately linear relationship between number of identified associated loci and the size of the sample, 
has been previously demonstrated38. GWAS studies of complex disease traits have consistently demonstrated the 
small effect size at individual associated variants. For behavioural traits more generally, the effect sizes are smaller, 
and the impact of other factors such as everyday experiences (e.g. degree of socialisation) may be large. As such, 
larger sample sizes will be needed to fully realise the allelic spectra of these traits38.
The largely negative findings from our gene-based and TWAS analyses may similarly be explained by sam-
ple size, but other factors intrinsic to the methods themselves may also be relevant. For example, although we 
restricted our gene-based association analysis to SNPs within each gene, the method does allow extension of 
the gene’s coordinates upstream and downstream to incorporate surrounding SNPs if there is a good rationale 
for doing so. Similarly, the analysis can be restricted to only certain SNPs within each gene if, for example, this 
is based on known functionality of certain SNPs. The method itself uses pruned principal components such that 
some variance is lost, albeit only a very small amount (0.1%).
A lack of overlap between the genetics of different aspects of social cognition such as emotional and cog-
nitive empathy may also be expected in light of the functional neuroimaging evidence of regional modularity. 
In particular, these imaging studies have identified different structures mediating simple and complex emotion 
recognition. Although there is great interest in using non-human primates for studying brain disorders, particu-
larly in view of their highly developed social behaviour, there are currently no models that have examined genetic 
association or gene disruption in social behaviour39.
Moreover, in addition to those brain processes involved in different aspects of social cognition, the method-
ology of different study designs will require the recruitment of additional processes in decoding the information 
presented. For example, one of Warrier et al.’s studies of cognitive empathy used images of eyes which form part of 
a standardised measure of cognitive empathy. Extracting the complex emotion depicted in only the eyes might be 
different from the same information from the whole face. Similarly, static images may involve different cognitive 
processes than animated images, and social information portrayed in abstract images or cartoons may involve 
yet other processes. From a methodological point of view, unravelling these elements into more fundamental, 
orthogonal dimensions of social cognition is a challenge. Similarly, to ensure ecological validity tasks must also 
necessarily involve real life scenarios which tends to undermine task simplification. This dilemma in the biolog-
ical research of social cognition will require more sophisticated methods of acquiring data, such as eye tracking 
which does overcome some of the aforementioned limitations. Similarly, brain imaging phenotypes may offer the 
opportunity for proxy measures of cognitive phenotypes at the psychological level40.
One further element confounding research into the genetics of social cognition is the developmental nature 
of the traits being examined. Different cognitive skills are acquired at different stages of childhood, and there 
is much inter-individual variation in these milestones. The longitudinal measurement of traits, using identical 
assessments at different points in childhood, will overcome this but does add an additional layer of complexity to 
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study design. However, this still does not explain why our results may fail to show any overlap with Coleman et 
al.’s, which essentially is based on the same trait in the same sample. There are many relatively arbitrary decisions 
that need to be made when undertaking GWAS. On consideration of such factors, we note some striking differ-
ences between the two studies (Supplementary Table 3). This includes consideration of population stratification 
and the imputation method used, both of which may be of major importance in explaining observed differences 
in results.
In summary, therefore, although we failed to find any genome-wide significant signals from our GWAS, and 
the TWAS signals that are significant are not easily interpretable, this does not rule out an important role for 
genetics in the development of the skills required to decode emotions from facial stimuli. Future larger studies 
will need to take into consideration the methodological issues outlined above to ensure both adequate power and 
trait validity.
Methods
participants. The Avon Longitudinal Study of Parents and Children (ALSPAC) is a longitudinal birth cohort 
with a sampling frame of all pregnant women living in the Avon region of the UK with expected delivery date 
between 1st April 1991 and 31st December 199241,42. Initially 14,541 pregnant women were recruited, with 14,062 
live births and 13,988 children who were alive at 1 year of age. Additional enrollment took place when the oldest 
children were 7 years of age. Questionnaires and face to face assessments have been carried out on participating 
children at specified time points measuring a variety of experiences, traits and developmental milestones. One 
such assessment discussed subsequently is the Diagnostic Analysis of Nonverbal Accuracy Scale (DANVA)21, 
which includes subtests to measure the ability to decode facial expressions. All participating children were invited 
to complete this at age 8 years (N = 7,488 invited). Please note that the study website contains details of all data 
that is available through a fully searchable data dictionary and variable search tool (http://www.bristol.ac.uk/
alspac/researchers/our-data/). Ethical approval for the study was obtained from the ALSPAC Ethics and Law 
Committee and the Local Research Ethics Committees, and the research carried out in accordance with the 
guidelines of both committees. Written informed consent was obtained from parents or a responsible legal guard-
ian for the child to participate. Assent was obtained from the child participants where possible.
phenotypes. The DANVA is a series of computer administered assessments that measure the ability to 
decode nonverbal information, including facial expression and tone of voice. The ‘faces’ subtest comprises 24 
photos of child faces, each showing one of four emotions: happy, sad, anger or fear. Each photo is presented on a 
computer screen for 2 seconds, during which time the child is prompted to respond whether they think the child 
portrayed is happy, sad, angry or fearful by clicking on the appropriate word presented on the screen below the 
image. Comprehension of meaning of the four words, ability to read them and understanding of the task itself 
is checked by an examiner before the child starts the assessment. From among those who completed the task 
(N = 7,303), 1,139 involved the tester recording the response on a datasheet (e.g. when there was technical diffi-
culties). For the purpose of the current study, all unrelated children who completed the DANVA were included 
and then filtered to leave only those individuals with a maximum of one DANVA item missing. A sample of 
4,919 children remained at this stage. As discussed subsequently, after further filtering based on the results of our 
population stratification analysis, a final sample of N = 4,780 children remained. All children also underwent IQ 
testing using the Wechsler Abbreviated Intelligence Scale (Pearson Clinical, London).
Genotypes. GWAS data were generated by Sample Logistics and Genotyping Facilities at Wellcome Sanger 
Institute and LabCorp (Laboratory Corporation of America) using support from 23andMe. Genotyping was 
performed using the Illumina HumanHap550 quad chip genotyping platform. The resulting raw genome-wide 
data were subjected to standard quality control methods as described in the unpublished ALSPAC quality con-
trol document made available to researchers using these data. Individuals were excluded on the basis of gender 
mismatches; minimal or excessive heterozygosity; disproportionate levels of individual missingness (>3%) and 
insufficient sample replication (IBD < 0.8). Population stratification was assessed by multidimensional scaling 
analysis and compared with HapMap II (release 22) European descent (CEU), Han Chinese, Japanese and Yoruba 
reference populations; all individuals with non-European ancestry were removed. SNPs with a minor allele fre-
quency of <1%, a call rate of <95% or evidence for violations of Hardy-Weinberg equilibrium (P < 5E-7) were 
removed. Cryptic relatedness was measured as proportion of identity by descent (IBD > 0.1). Related subjects 
that passed all other quality control thresholds were retained during subsequent phasing and imputation. 9,115 
subjects and 500,527 SNPs passed these quality control filters.
imputation. ALSPAC mothers were genotyped using the Illumina human660W-quad array at Centre 
National de Génotypage (CNG) and genotypes were called with Illumina GenomeStudio. 477,482 SNP genotypes 
in common between the sample of mothers and sample of children were combined. SNPs with genotype missing-
ness above 1% due to poor quality (11,396 SNPs removed) were removed, and a further 321 subjects were removed 
due to potential ID mismatches. This resulted in a dataset of 17,842 subjects containing 6,305 duos and 465,740 
SNPs (112 were removed during liftover and 234 were out of HWE after combination). Haplotypes were esti-
mated using ShapeIT (v2.r644)43 which utilises relatedness during phasing. Phased version of the 1000 genomes 
reference panel (Phase 1, Version 3) were obtained from the Impute2 reference data repository (phased using 
ShapeIt v2.r64444, haplotype release date Dec 2013). Imputation of the target data was performed using Impute 
V2.2.244 against the reference panel (all polymorphic SNPs excluding singletons), using all 2,186 reference hap-
lotypes (including non-Europeans). In total, 27,449,291 SNPs were tested (SNPS with MAF ≥ 0.01 = 9,128,173).
population structure. We performed an additional layer of population structure analysis. We first under-
took analysis of population structure using the Roslin et al. (2016) QC’d 1000 Genomes phase 3 data as ref. 45. All 
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non-imputed (i.e. Illumina) SNPs that are shared between ALSPAC and 1000 Genomes across the genome were 
used to investigate population structure after LD pruning (N = 106,084). After LD pruning, GCTA [v1.9.1]46 was 
used to generate a genetic relationship matrix which was in turn employed by GCTA to generate principal compo-
nents. The first two eigenvectors thereby generated are visualized in the Supplementary Fig. 1 (Population struc-
ture for ALSPAC using Roslin et al. QC’d 1000 Genomes). Although the sample appears to cluster with the 1000 
genomes EUR samples, we further investigated this by repeating the population stratification analysis against the 
EUR only 1000 genomes sample (Supplementary Fig. 2: Population structure for ALSPAC against 1000 Genomes 
EUR-only sample) which demonstrated some heterogeneity. Through a series of iterations, sequentially removing 
outliers and recalculating structure, a total of 222 ALSPAC individuals were removed and a well-clustered sample 
was generated for subsequent analyses (N = 4,780).
LDSC. LD score regression (LDSC)23 was used also to investigate population stratification. This method, which 
regresses test statistic on variant LD scores across the genome under a polygenic model, provides estimation of 
heritability (slope) and confounding bias (intercept minus 1). With true polygenicity, the intercept approaches 1, 
but with population stratification the intercept shows positive deviation.
Genome-wide association study. The final sample of 4,780 individuals underwent GWAS of auto-
somes using methods implemented in SNPTEST47 [v2.5.2]. The total DANVA score, indicating number of 
correct responses, was used as the quantitative trait of interest, with age and sex as covariates. DANVA scores 
were first cubed to normalize residuals [Supplementary Fig. 3a: distribution of DANVA scores in total sample; 
Supplementary Fig. 3b: distribution of DANVA-cubed scores in total sample]. Frequentist tests were performed 
for each SNP using an additive model, with a score test being employed to manage genotype uncertainty at each 
imputed SNP. Phenotypes were mean centred and scaled to have a variance of 1. QQ plots of p-values were gener-
ated, stratified according to allele frequency. The results are visually summarized in Manhattan plots and regional 
plots of top SNPs. In total, 27,449,291 SNPs were tested (SNPs with MAF ≥ 0.01 = 9,128,173).
Generalized gene-set analysis. SNP P-values generated in the GWAS were then used in a genome-wide 
gene-by-gene analysis. Specifically, MAGMA [v.1]25 was used to undertake a gene-level linear regression. This 
method projects the matrix of overlapping SNPs for each gene (which will vary by gene) onto its principal com-
ponents, which are then used as predictors for phenotype in a linear regression model. In the region of 15,000 
genes are included in the model.
transcriptome-wide association analysis. A transcriptome-wide association (TWA) analysis was 
implemented in FUSION [V.1]26. Briefly, gene expression levels are imputed into the dataset based on the results 
of reference data in which gene expression and genotyping have both been performed. This imputation is based 
on the weights that have been assigned to SNPs in the reference data using a liner predictive model. Association 
can then be tested between trait and imputed expression. In this way, this method essentially examines how 
strongly variants associated with expression are also associated with the trait, and under certain circumstances 
has greater power than traditional SNP-based GWAS. We used GTEx whole blood (release V.6)17 for reference 
data using pre-computed weights by the FUSION development team.
Polygenic risk scores. Polygenic Risk Scores were calculated using methods implemented in PRSice-248. Results 
from published GWAS studies of schizophrenia27, bipolar disorder29, educational attainment30, cognition30, ASD27 
and obsessive-compulsive disorder31 were used for calculating scores. All scores were generated using the default 
average score statistic, and subsequent trait regression was performed with sex as covariant as with all other anal-
yses. Clumping was performed in PRSice using the default r2 of 0.1 and 250 kb windows. Default PRSice p-value 
thresholds were used, and permutation using the default 10,000 iterations was used to generate an empirical 
p-value.
Data availability
The datasets generated during and/or analysed during the current study are available for download on the journal 
website.
Received: 13 August 2019; Accepted: 13 March 2020;
Published: xx xx xxxx
References
 1. Kennedy, D. P. & Adolphs, R. The social brain in psychiatric and neurological disorders. Trends Cogn. Sci. 16, 559–572, https://doi.
org/10.1016/j.tics.2012.09.006 (2012).
 2. Adolphs, R. Social cognition and the human brain. Trends Cogn. Sci. 3, 469–479, https://doi.org/10.1016/S1364-6613(99)01399-6 
(1999).
 3. Walter, H. Social Cognitive Neuroscience of Empathy: Concepts, Circuits, and Genes. Emot. Rev. 4, 9–17, https://doi.
org/10.1177/1754073911421379 (2012).
 4. Leppanen, J. M. & Nelson, C. A. Tuning the developing brain to social signals of emotions. Nat. Rev. Neurosci. 10, 37–47, https://doi.
org/10.1038/nrn2554 (2009).
 5. Miller, S. A. Children’s Understanding of Second-Order Mental States. Psychol. Bull. 135, 749–773, https://doi.org/10.1037/a0016854 
(2009).
 6. Saxe, R. & Baron-Cohen, S. The neuroscience of theory of mind. Soc. Neurosci. 1, I–Ix, https://doi.org/10.1080/17470910601117463 
(2006).
 7. Baron-Cohen, S. Acquiring a conception of mind: A review of psychological research and theory. J. Child. Psychol. Psyc 39, 284–284 
(1998).
7Scientific RepoRtS |         (2020) 10:7469  | https://doi.org/10.1038/s41598-020-62693-6
www.nature.com/scientificreportswww.nature.com/scientificreports/
 8. Gonzalez-Liencres, C., Shamay-Tsoory, S. G. & Brune, M. Towards a neuroscience of empathy: ontogeny, phylogeny, brain 
mechanisms, context and psychopathology. Neurosci. Biobehav. Rev. 37, 1537–1548, https://doi.org/10.1016/j.neubiorev.2013.05.001 
(2013).
 9. Adolphs, R. The social brain: Insights from cognitive neuroscience. Prog. Nat. Sci. 17, 99–105 (2007).
 10. Happe, F. & Frith, U. Annual Research Review: Towards a developmental neuroscience of atypical social cognition. J. Child. Psychol. 
Psychiatry 55, 553–577, https://doi.org/10.1111/jcpp.12162 (2014).
 11. Hughes, C. & Cutting, A. L. Nature, nurture, and individual differences in early understanding of mind. Psychol. Sci. 10, 429–432, 
https://doi.org/10.1111/1467-9280.00181 (1999).
 12. Hughes, C. et al. Origins of individual differences in theory of mind: From nature to nurture? Child. Dev. 76, 356–370, https://doi.
org/10.1111/j.1467-8624.2005.00850_a.x (2005).
 13. Woodbury-Smith, M. & Scherer, S. W. Progress in the genetics of autism spectrum disorder. Dev. Med. Child. Neurol. 60, 445–451, 
https://doi.org/10.1111/dmcn.13717 (2018).
 14. Weiner, D. J. et al. Polygenic transmission disequilibrium confirms that common and rare variation act additively to create risk for 
autism spectrum disorders. Nat. Genet. 49, 978–985, https://doi.org/10.1038/ng.3863 (2017).
 15. Grove, J. et al. Identification of common genetic risk variants for autism spectrum disorder. Nat. Genet. 51, 431–+, https://doi.
org/10.1038/s41588-019-0344-8 (2019).
 16. Warrier, V. et al. Genome-wide meta-analysis of cognitive empathy: heritability, and correlates with sex, neuropsychiatric conditions 
and cognition. Mol. Psychiatr. 23, 1402–1409, https://doi.org/10.1038/mp.2017.122 (2018).
 17. Lonsdale, J. et al. The Genotype-Tissue Expression (GTEx) project. Nat. Genet. 45, 580–585, https://doi.org/10.1038/ng.2653 (2013).
 18. Warrier, V. & Baron-Cohen, S. Genetic contribution to ‘theory of mind’ in adolescence. Sci Rep 8, ARTN 346510.1038/s41598-018-
21737-8 (2018).
 19. Boraston, Z., Blakemore, S. J., Chilvers, R. & Skuse, D. Impaired sadness recognition is linked to social interaction deficit in autism. 
Neuropsychologia 45, 1501–1510, https://doi.org/10.1016/j.neuropsychologia.2006.11.010 (2007).
 20. Coleman, J. R. I. et al. Genome-wide association study of facial emotion recognition in children and association with polygenic risk 
for mental health disorders. Am. J. Med. Genet. B Neuropsychiatr. Genet 174, 701–711, https://doi.org/10.1002/ajmg.b.32558 (2017).
 21. Nowicki, S. & Carton, J. The Measurement of Emotional Intensity from Facial Expressions. J. Soc. Psychol. 133, 749–750, https://doi.
org/10.1080/00224545.1993.9713934 (1993).
 22. Altshuler, D. M. et al. An integrated map of genetic variation from 1,092 human genomes. Nature 491, 56–65, https://doi.
org/10.1038/nature11632 (2012).
 23. Bulik-Sullivan, B. K. et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. 
Nat. Genet. 47, 291–295, https://doi.org/10.1038/ng.3211 (2015).
 24. Machiela, M. J. & Chanock, S. J. LDlink a web-based application for exploring population-specific haplotype structure and linking 
correlated alleles of possible functional variants. Bioinformatics 31, 3555–3557.
 25. de Leeuw, C. A., Mooij, J. M., Heskes, T. & Posthuma, D. MAGMA: Generalized Gene-Set Analysis of GWAS Data. Plos Comput Biol 
11, ARTN e100421910.1371/journal.pcbi.1004219 (2015).
 26. Gusev, A. et al. Integrative approaches for large-scale transcriptome-wide association studies. Nat. Genet. 48, 245–252, https://doi.
org/10.1038/ng.3506 (2016).
 27. Autism Spectrum Disorders Working Group of The Psychiatric Genomics Consortium. Meta-analysis of GWAS of over 16,000 
individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia. Mol. 
Autism 8, 21, https://doi.org/10.1186/s13229-017-0137-9 (2017).
 28. Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated 
genetic loci. Nature 511, 421–427, https://doi.org/10.1038/nature13595 (2014).
 29. Stahl, E. A. et al. Genome-wide association study identifies 30 loci associated with bipolar disorder. Nat. Genet. 51, 793–803, https://
doi.org/10.1038/s41588-019-0397-8 (2019).
 30. Lee, J. J. et al. Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 
million individuals. Nat. Genet. 50, 1112–1121, https://doi.org/10.1038/s41588-018-0147-3 (2018).
 31. International Obsessive Compulsive Disorder Foundation Genetics Consortium. Revealing the complex genetic architecture of 
obsessive-compulsive disorder using meta-analysis. Mol. Psychiatry 23, 1181–1188, https://doi.org/10.1038/mp.2017.154 (2018).
 32. Tran, S. S. et al. Widespread RNA editing dysregulation in brains from autistic individuals. Nat. Neurosci. 22, 25–36, https://doi.
org/10.1038/s41593-018-0287-x (2019).
 33. Parras, A. et al. Autism-like phenotype and risk gene mRNA deadenylation by CPEB4 mis-splicing. Nature 560, 441–446, https://
doi.org/10.1038/s41586-018-0423-5 (2018).
 34. Ghahramani Seno, M. M. et al. Gene and miRNA expression profiles in autism spectrum disorders. Brain Res. 1380, 85–97, https://
doi.org/10.1016/j.brainres.2010.09.046 (2011).
 35. Noor, A. et al. Disruption at the PTCHD1 Locus on Xp22.11 in Autism spectrum disorder and intellectual disability. Sci. Transl. 
Med. 2, 49ra68, https://doi.org/10.1126/scitranslmed.3001267 (2010).
 36. Benesh, A. E., Fleming, J. T., Chiang, C., Carter, B. D. & Tyska, M. J. Expression and localization of myosin-1d in the developing 
nervous system. Brain Res. 1440, 9–22, https://doi.org/10.1016/j.brainres.2011.12.054 (2012).
 37. Stone, J. L., Merriman, B., Cantor, R. M., Geschwind, D. H. & Nelson, S. F. High density SNP association study of a major autism 
linkage region on chromosome 17. Hum. Mol. Genet. 16, 704–715, https://doi.org/10.1093/hmg/ddm015 (2007).
 38. Panagiotou, O. A., Willer, C. J., Hirschhorn, J. N. & Ioannidis, J. P. The power of meta-analysis in genome-wide association studies. 
Annu. Rev. Genomics Hum. Genet. 14, 441–465, https://doi.org/10.1146/annurev-genom-091212-153520 (2013).
 39. Izpisua Belmonte, J. C. et al. Brains, genes, and primates. Neuron 86, 617–631, https://doi.org/10.1016/j.neuron.2015.03.021 (2015).
 40. Glahn, D. C., Thompson, P. M. & Blangero, J. Neuroimaging endophenotypes: strategies for finding genes influencing brain structure 
and function. Hum. Brain Mapp. 28, 488–501, https://doi.org/10.1002/hbm.20401 (2007).
 41. Fraser, A. et al. Cohort Profile: The Avon Longitudinal Study of Parents and Children: ALSPAC mothers cohort. Int. J. Epidemiol. 42, 
97–110, https://doi.org/10.1093/ije/dys066 (2013).
 42. Boyd, A. et al. Cohort Profile: The ‘Children of the 90s’-the index offspring of the Avon Longitudinal Study of Parents and Children. 
Int. J. Epidemiol. 42, 111–127, https://doi.org/10.1093/ije/dys064 (2013).
 43. Delaneau, O., Marchini, J. & Zagury, J. F. A linear complexity phasing method for thousands of genomes. Nat. Methods 9, 179–181, 
https://doi.org/10.1038/Nmeth.1785 (2012).
 44. Howie, B. N., Donnelly, P. & Marchini, J. A Flexible and Accurate Genotype Imputation Method for the Next Generation of 
Genome-Wide Association Studies. Plos Genet 5, ARTN e100052910.1371/journal.pgen.1000529 (2009).
 45. Roslin, N. M., Weili, L., Paterson, A. D. & Strug, L. J. Quality control analysis of the 1000 Genomes Project Omni2.5 genotypes. 
BioRxiv, https://doi.org/10.1101/078600 (2016).
 46. Yang, J. A., Lee, S. H., Goddard, M. E. & Visscher, P. M. GCTA: A Tool for Genome-wide Complex Trait Analysis. Am. J. Hum. Genet. 
88, 76–82, https://doi.org/10.1016/j.ajhg.2010.11.011 (2011).
 47. Marchini, J., Howie, B., Myers, S., McVean, G. & Donnelly, P. A new multipoint method for genome-wide association studies by 
imputation of genotypes. Nat. Genet. 39, 906–913, https://doi.org/10.1038/ng2088 (2007).
 48. Choi, S. W. & O’Reilly, P. F. PRSice-2: Polygenic Risk Score software for biobank-scale data. Gigascience 8, https://doi.org/10.1093/
gigascience/giz082 (2019).
8Scientific RepoRtS |         (2020) 10:7469  | https://doi.org/10.1038/s41598-020-62693-6
www.nature.com/scientificreportswww.nature.com/scientificreports/
Acknowledgements
We are extremely grateful to all the families who took part in this study, the midwives for their help in recruiting 
them, and the whole ALSPAC team, which includes interviewers, computer and laboratory technicians, clerical 
workers, research scientists, volunteers, managers, receptionists and nurses. The UK Medical Research Council 
and Wellcome (Grant ref: 102215/2/13/2) and the University of Bristol provide core support for ALSPAC. This 
publication is the work of the authors who will serve as guarantors for the contents of this paper. A comprehensive 
list of grants funding is available on the ALSPAC website (http://www.bristol.ac.uk/alspac/external/documents/
grant-acknowledgements.pdf). GWAS data was generated by Sample Logistics and Genotyping Facilities at 
Wellcome Sanger Institute and LabCorp (Laboratory Corporation of America) using support from 23andMe. 
We thank The Centre for Applied Genomics (TCAG), which is funded by Genome Canada through the Ontario 
Genomics Institute, and the Canada Foundation for Innovation (CFI), as well as the University of Toronto 
McLaughlin Centre. MWS was supported by a Clinical Investigatorship Award from the Canadian Institutes of 
Health Research (CIHR) Institute of Genetics during this study; SWS holds the GlaxoSmithKline-CIHR Chair 
in Genome Sciences at the University of Toronto and The Hospital for Sick Children. Funding for the project was 
also provided by the Wellcome Trust, Autism Speaks and CIHR.
Author contributions
M.W.S. conceived the study in consultation with A.P., P.S. and S.W.S. He conducted all analyses supported by A.P. 
M.W.S., A.P., P.S. and S.W.S. all contributed to the final manuscript.
competing interests
SWS is on the Scientific Advisory Committees of Population Bio and Deep Genomics, and intellectual property 
from his research held at the Hospital for Sick Children is licensed to Athena Diagnostics, and separately 
Lineagen. These relationships did not influence data interpretation or presentation during this study, but are 
still being disclosed for potential future considerations. MWS served as national co-ordinator (UK) for Servier, 
a pharmaceutical company, in connection with two planned ASD clinical trials. This relationship did not 
influence data interpretation or presentation. Other authors declare no conflict of interest.
Additional information
Supplementary information is available for this paper at https://doi.org/10.1038/s41598-020-62693-6.
Correspondence and requests for materials should be addressed to M.R.W.-S.
Reprints and permissions information is available at www.nature.com/reprints.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2020
